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The Crimean-Congo hemorrhagic fever (CCHF) virus (CCHFV) is a tick-borne
virus, whose viral RNA consists of S, L, and M segments. The virus is migrating
through the ticks with animals and migratory birds and the geographical distribution
can be investigated based on genetic analysis. To better understand the connection
between the seropositivity and the mortality rate, the key factor could be the temporal
and spatial analysis of the different strains. In this study, serum samples (n= 26) were
selected from CCHFV RNA-positive patients and subjected to sequence analysis of
the gene regions encoding the S segments. According to the neighbor-joining analysis,
the obtained partial sequences were linked to the European strain. The strains were
closely related to Turkey-Kelkit06, Turkey 200310849 viruses, and viruses from
Russia and Kosovo. The comparison with previously analyzed isolates from the
GenBank showed 95%–99% sequence similarity. The isolates in phylogenetic
branches were divided into two groups. AST, platelet, and APTT levels were found
signiﬁcantly higher in Group 2 compared to Group 1. Nucleotide differences can be
prognostic factor in CCHF disease. Increasing CCHF cases not originating from local
isolates were circulating strains imported from different neighboring countries of
Turkey. The results show new evidence to the emerging threat of the CCHF disease.
Keywords: Crimean-Congo hemorrhagic fever virus, S segment, genotypic
analysis
Introduction
Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic disease caused
by the CCHF virus (CCHFV). The virus is primarily transmitted to humans by a
bite of Hyalomma marginatum. Birds are playing an important role in the
transmission of the virus, since they are resistant to it [1]. CCHF is mainly found
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in Africa, Southeast Europe, and Asia. Tokat, a province of Turkey, is known
for the CCHF endemic [2, 3]. In Turkey, 900 new CCHF cases are currently
found yearly, and a total of 9,787 cases have been reported to the Minister of
Health from 2002 through December 2015, of whom 469 (4.79%) died [4].
CCHF in humans starts with non-speciﬁc symptoms, such as general muscle
aches, headache, nausea, vomiting, and diarrhea, and progresses to hemorrhagic
syndrome [5]. Death is mostly caused by the development of hepatorenal
insufﬁciency, acute respiratory distress syndrome, and disseminated intra-
vascular coagulopathy [3]. The mortality rate of CCHF is between 3% and
30% [4]. In Turkey, it is between 2% and 12% [6].
The CCHFV is a single-stranded negative-polarity RNA tick-borne virus of
the genus Nairovirus in the new order of Bunyavirales [7]. Viral RNA consists of
three segments, namely S, L, andM segments. The small (S) segment of the genome
encodes the major protein of nucleocapsid, the medium (M) segment encodes a
glycoprotein precursor, resulting in the two envelope glycoproteins, G1 and G2, and
the large (L) segment encodes an RNA-dependent RNA polymerase [8, 9]. The
recombination in S segment of CCHFV was eventually demonstrated by Lukashev
[10] in 2005. The results of other studies depicted evidence of potential recombi-
nation among S segment in CCHFV [2]. Genetic alterations in RNA viruses are
often caused by mutations, but reassortment can also result in a different genetic
structure. Recently, it has been emphasized that global warming might affect the
migration patterns of birds and maturation processes of ticks creating new habitats
for ticks [2]. Furthermore, it has also been suggested that the increased tick
populations might play a role in the increased incidence of tick-borne infectious
diseases [11]. Nucleotide sequencing has shown a recombination in the S segment of
the CCHFV [2]. The aim of this study is to investigate genotypic relationship in the
S segment of CCHFV obtained from patients in endemic region of Turkey.
Materials and Methods
This project was approved by the ethics committee of Gaziosmanpasa
University (number: 15/KAEK/048). In this study, serum samples of 26 patients
diagnosed with CCHF were analyzed. All serum samples were stored at −80 °C
until processed.
RNA isolation
RNA was collected with the Bosphore CCHFV Quantiﬁcation Kit (Anatolia
Geneworks, Turkey). Lyophilized proteinase K and carrier RNA were liqueﬁed
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with buffers and RNase-free water. In total, 400 μl of serum was added to 10 μl
carrier RNA (1 mg/ml) and 20 μl proteinase K (10 mg/ml), and RNA isolation was
performed on the Magnesia 16 isolation device (Anatolia Geneworks), in accor-
dance with the manufacturer’s recommendation. All collected RNAs were stored
at +4 °C, if used within a short period of time or at −20 °C.
Polymerase chain reaction (PCR) stage
An amount of 10 μl of RNA was added to 15 μl PCR Master Mix
(Bosphore® CCHFV Quantiﬁcation Kit v1) and PCR was performed with
Montania 4896 Real-Time PCR (Anatolia Geneworks). The thermal protocol
was as follows: initial denaturation at 95 °C for 14.5 min followed by 50 cycles of
denaturation at 95 °C for 0.5 min, and binding and synthesis at 52 °C for 1.5 min.
After a total of 50 cycles, the PCRwas completed by incubating at 22 °C for 5 min.
The primer sequences used in the PCR are proprietary to the manufacturer.
Sequencing stage
Post-PCR puriﬁcation was performed with the Spin Column Method
Bosphore® PCR Product Puriﬁcation Spin Kit (Anatolia Geneworks). The DNA
concentrations were measured by nanodrop. The concentration of >25 ng/μl
was determined as the study’s acceptance criteria. A total of 27 samples with
DNA concentrations >25 ng/μl were sequenced. DNA samples were prepared to
be about 250 ng with dH2O with a total volume of 20 μl. The relevant primer and
sequencing mix (Bosphore® CCHFV Sequencing Kit; Anatolia Geneworks)
prepared by the manufacturer were added to the samples. After the PCR, 2 μl of
3 M sodium acetate (pH = 5.2), 2 μl of 100 mM Na2EDTA (pH = 8), and 1 μl
of 20 mg/ml glycogen were added to the tubes and mixed for 20–30 s. An
amount of 120 μl of cold 95% ethanol (−20 °C) was added followed by a
centrifugation at 12,500 × g for 15 min. The supernatant was removed and the
pellet was mixed with 240 μl of cold 70% ethanol (−20 °C). After centrifugation
(12,500 × g for 5 min), the pellet was incubated at 37 °C for 1 h. DNA was
reconstituted with 40 μl sample loading solution and incubated at 37 °C for
5 min. The sequencing was performed by a CEQ 8000 Genetic Analyzer
(Beckman Coulter, USA).
A total of 450 base-pair section of the S segment was ampliﬁed and 360 base-
pair section was sequenced. The Clustal W program [12] was used to analyze viral
nucleotide and amino acid sequences, while BLAST analysis of sequencing results
was performed according to the National Center for Biotechnology Information
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GenBank (http://blast.ncbi.nlm.nih.gov). All isolates were compared with previ-
ously genetically analyzed isolates.
Phylogenetic analyses
Phylogenetic analyses were conducted by MEGA version 6 [13]. Nucleotide
sequences of strains already described were obtained from GenBank and used
to construct alignments and phylogeny. The accession numbers of these strains
were: complete S segment of Senegal DQ211639, Nigeria KY484036, S Africa
DQ211646, S Africa DQ211647, China DQ211642, Russia Drosdov DQ211643,
Russia DQ206447, Turkey 200310849-DQ211636, Turkey-Kelkit06 GQ337053,
and Kosovo AF428144 and partial S segments. Neighbor-joining tree was
constructed using Kimura 2 Parameter substitution model [14]. The branching
pattern was statistically evaluated by bootstrap analysis of 1,000 replicates.
Statistical analysis
The difference between levels of aspartate aminotransferase (AST), alanine
aminotransferase (ALT), white blood cell (WBC), platelet, prothrombin time (PT),
and activated partial thromboplastin time (APTT) in Groups 1 and 2 were
investigated with unpaired t test. The statistical signiﬁcance level of p was
0.05. Statistical analysis was performed using commercial software (IBM SPSS
Statistics 20, SPSS Inc., an IBM Co., Somers, NY, USA). Data are presented as
mean± SEM. *p< 0.05, **p< 0.01, ***p< 0.001.
Results
Sixteen (61.5%) of the patients were male and 10 (38.5%) were female;
25 (96.2%) of them were living in Tokat, 1 (3.8%) of them in Amasya. Twenty
patients (77%) were living in the village and six patients (13%) were living in the
city. Evaluation of the patients’ occupation showed that most of them were farmers
(n= 14, 53.8%). The mean age was 50± 6.8 year. Twenty-one patients (80.8%)
had tick bite, whereas ﬁve (19.2%) were not fully aware of the tick bite. The
neighboring joining analysis of the partial sequence obtained from the patients
suggested that ticks are related to the European strain. We also found that our viral
isolates were closely related to Turkey-Kelkit06 and Turkey 200310849 viruses,
as well as viruses from Russia and Kosovo. Their amino acid sequences were also
similar. The isolates designated as KRM are shown in the phylogenetic tree in
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Figure 1. The comparison with previously analyzed isolates from the GenBank
showed 95%–99% sequence similarity. The names of the compared isolates and
their GenBank access numbers are shown in Table I. The isolates were separated
in two distinct subbranches. According to the distinct subbranch, strains were
separated into two groups. Group 1 consisted of KRM 17, KRM 28, KRM 2,
KRM 13, KRM 7, KRM 35, KRM 37, KRM 16, KRM 4, KRM 22, KRM 5, KRM
30, KRM 3, KRM 5, KRM 24, KRM 29, KRM 21, and KRM 15 and Group 2
consisted of KMR 10, KRM 19, KRM 26, KRM 27, KRM 32, KRM 38, KRM 14,
Figure 1. Demonstration of CCHF-diagnosed isolates in the phylogenetic tree
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and KRM 40. AST and APTT levels were signiﬁcantly increased in Group 2
compared to Group 1 (**p< 0.01). Platelet level was signiﬁcantly increased in
Group 2 compared to Group 1 (***p< 0.001). There were no signiﬁcant differ-
ence in ALT, PT, and WBC levels in Group 2 compared to Group 1 (p> 0.05).
The level of the laboratory parameters and statistical data of Groups 1 and 2 were
shown in Table II. The statistical data of the laboratory parameters of Groups 1 and
2 was shown in Figure 2.
Discussion
The CCHFV was ﬁrst isolated in 2002 in the province of Tokat, Turkey [6].
The number of CCHFV-associated cases has increased over the years. Most CCHF
cases occur in Kelkit valley and surrounding areas including Tokat, Sivas, Yozgat,
and Çorum [4].
People who work in farms and slaughterhouses, live in rural areas, and are in
contact with blood and tissue of infected animals are at higher risk of CCHF
infection [4]. Seropositivity was reported in 79% of the sera collected from 400
cattle in Tokat region [15]. Moreover, Kırbas¸ et al. [16] examined 100 cattle and
100 sheeps that belonged to the households in the endemic regions, which
Table I. Names and GenBank accession numbers of the compared isolates
No.
The name of the
compared isolates
Accession
numbers in
the GenBank No.
The name of the
compared isolates
Accession
numbers in
the GenBank
1 Tokat 555-2010 HQ685839 18 Bingol-2008 FJ601862
2 Tokat 92-2008 FJ601882 19 Samsun-2008 FJ60186
3 Tokat 89-2008 FJ601881 20 Sivas 167-2008 FJ601859
4 Turkey/Yozgat 20-2012 KR059974 21 Samsun-2008 FJ601861
5 Yozgat 19-2012 KR092375 22 Tokat 3944-2009 HQ188914
6 Turkey/Corum 22-2012 KR059958.1 23 Yozgat 714-2010 HQ188920
7 Sivas 561-2010 HQ188917 24 Sivas 515-2009 HQ173898
8 GOU-OT 07 EU727456 25 Kastamonu 627-2010 HQ188913
9 Tokat 1728-2009 HQ173902 26 Turkey_812955 KY362517
10 Yozgat 207-2011 KR092377 27 Turkey/Corum 434-2011 KR059970
11 Tokat 1731-2009 HQ659777 28 Kastamonu 627-2010 HQ188913
12 Yozgat 8-2007 FJ601871 29 Tokat 1731-2009 HQ659777
13 Yozgat 19-2012 KR092375 30 Corum 6-2007 FJ601876
14 Turkey_812955 KY362517 31 Yozgat 207-2011 KR092377
15 Iran-Isfahan 78 KJ027522 32 Kastamonu 229-2010 HQ675009
16 Corum 618-2009 HQ675004 33 Turkey/Çorum 22-2012 HQ188914.1
17 Tokat 1728-2009 HQ173902
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Table II. The statistical data of the laboratory parameters of CCHF strains
Group 1 (mean± SEM) Group 2 (mean± SEM) p value
AST 72.79± 14.32 143.9± 16.89** 0.0031
ALT 43.71± 8.037 62.53± 6.315 0.0742
Platelet 123,778± 9,191 68,059± 5,951*** <0.0001
WBC 2,523± 224.9 2,132± 142.9 0.1509
PT 13.36± 0.3475 14.21± 0.3619 0.0987
APTT 33.78± 2.695 33.78± 2.695** 0.0020
Note: The table shows the blood parameters of Groups 1 and 2. Data are presented as mean± SEM.
Unpaired t test was used (**p< 0.01, ***p< 0.001), Group 1 compared to Group 2. CCHF: Crimean-Congo
hemorrhagic fever; SEM: standard error of measurement; AST: aspartate aminotransferase; ALT: alanine
aminotransferase; WBC: white blood cell; PT: prothrombin time; APTT: activated partial thromboplastin
time.
Figure 2. The difference between laboratory levels in Groups 1 and 2. (A) AST levels were
signiﬁcantly increased in Group 2 compared to Group 1 (**p< 0.01). (B) There were no signiﬁcant
difference in ALT level in Group 2 compared to Group 1 (p> 0.05). (C) Platelet level was
signiﬁcantly increased in Group 2 compared to Group 1 (***p< 0.001). (D) There were no
signiﬁcant difference in WBC level in Group 2 compared to Group 1 (p> 0.05). (E) There were no
signiﬁcant difference in PT level in Group 2 compared to Group 1 (p> 0.05). (F) APTT levels were
signiﬁcantly increased in Group 2 compared to Group 1 (**p< 0.01)
GENOTYPIC ANALYSIS CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS 85
Acta Microbiologica et Immunologica Hungarica 66, 2019
included Elazıg˘, Samsun, Sivas, Tokat, and Yozgat, and found that 17% of
cattle and 37% of sheeps were positive with CCHF viral IgG. The CCHF positivity
rates in this region may be the result of contamination with blood and tissues of
these animals.
In this study, most of the patients were living in the endemic region, which
supports the notion that living in the rural areas and being in contact with animals
are the risk factors for CCHF. Reports have shown that infectious transmission
may occur not only through tick bites, but also through nosocomial outbreaks,
direct contact with blood or bloody secretions of the patient with severe
manifestations, and through airway [17]. In this study, the presence of tick bite
in 21 of the patients (80.8%) suggests that the most important source of infec-
tion in endemic areas is still tick bites. CCHF poses a great risk of farmers,
slaughterhouse workers, veterinarians, animal caregivers, and healthcare workers
[18]. In addition, a signiﬁcant proportion of the patients were farmers (53.8%) and
there were no healthcare workers among the patients. These results are in
agreement with Yilmaz et al. (51.8%) [19]. Based on this, we suggest that it
is important to inform the population in endemic regions to take precautions
against tick bites.
Over the years, a genetic variability between the viruses in different
geographical regions has been noticed. The sequence of the S segment of the
CCHFV was used in phylogenetic analyses. The S segment plays a role in the
encapsulation of viral RNA by forming ribonucleoprotein complexes [20] and is
important in assessing the topology of viruses [2]. Based on the CCHF viral S
segment sequences, there are seven genetic groups showing different geographical
distribution characteristics [21]. In the CCHFV, the genetic variability rates
between the segments are diverse, as it is up to 30% at the nucleotide level;
however, variability is much lower at the amino acid level [22].
In 2004, Hewson et al. [23] performed nucleotide sequencing of S and M
segments and reported genetic differences between isolates and suggested that
these differences are due to reassortment. The study from Iran found a recombi-
nation in the S segment of CCHFV and emphasized that this could contribute to
epidemiological and vaccination studies [24].
A number of studies showed that the CCHFV responsible for the infections
in Turkey belongs to the European strain I, which is also widespread in
southwestern Russia and the Balkan peninsula [25, 26], whereas others reported
that virus belongs to European strain II, which includes Greece AP92 [27, 28].
In 2010, Ozkaya et al. [11] showed no genetic variability in the S segment in
Turkish isolates and found that they were closely related to the European strain.
Moreover, in 2012, Kalaycıoglu et al. sequenced the S segment and found that it
was genetically homogeneous. It has been reported that the CCHFVs that cause
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infections in Turkey are closely related and are associated with the European strain
I class that includes Eastern Europe-Russia (Drosdov, Kashmanov and Balkan
peninsula, Kosovo, and Bulgaria) [29]. In 2016, Chinikar et al. [24] indicated that
their study provides evidence of recombination in the S segment of CCHFV and
switching of different genomic regions between different strains by recombination
could contribute to CCHFV diversiﬁcation and evolution.
Consistent with previous studies, this study showed that the majority of
isolates were clustered in the genetic group V, which represents the geographical
area of Europe/Turkey. The increase in CCHF cases in Turkey was thought to be
related to the increased number of local viral isolates rather than the introduction of
new strains from neighboring countries [27]. Furthermore, climate change has also
been suggested to be responsible for the increase in tick-borne infectious diseases
by facilitating the growth of the tick population [21].
Cevik et al. [30] reported that laboratory abnormalities, which include
leukopenia and thrombocytopenia, high levels of ALT and AST, prolonged
bleeding time, PT and APTT, were independent predictors of fatality in CCHF
disease. Based on the nucleotide differences, the strains were separated by the two
subbranches in the phylogenetic tree. The strains in these branches were divided
into two groups and were statistically analyzed. AST, platelet, and APTT levels
were found signiﬁcantly higher in Group 2 compared to Group 1. Nucleotide
differences can be a prognostic factor in CCHF disease.
The results of this study suggest that CCHFV’s genetic variations may be
transported through migrating birds, as well as through viremic animals from
countries to the east of Russia and Turkey [2, 11]. Therefore, the proliferation of
tick populations and the increased incidence of tick-borne infectious diseases will
have vital importance, especially for endemic regions.
Along with the prevalence studies in endemic areas, it is vital to conduct
genotypic research in order to establish a countrywide data bank. This information
will enable a better understanding of this virus, help to prevent the spread of
CCHF, increase the number of treatment options, and help to develop vaccines to
prevent the disease.
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